Cargando…

EEG alterations during treatment with olanzapine

The aim of this naturalistic observational study was to investigate EEG alterations in patients under olanzapine treatment with a special regard to olanzapine dose and plasma concentration. Twenty-two in-patients of a psychiatric university ward with the monodiagnosis of paranoid schizophrenia (ICD-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Degner, Detlef, Nitsche, Michael A., Bias, Frank, Rüther, Eckart, Reulbach, Udo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291825/ https://www.ncbi.nlm.nih.gov/pubmed/21431467 http://dx.doi.org/10.1007/s00406-011-0208-4

Ejemplares similares

Non-medical use of olanzapine by people on methadone treatment
por: James, Philip David, et al.
Publicado: (2016)

A case series of serious and unexpected adverse drug reactions under treatment with cariprazine
por: Heck, Johannes, et al.
Publicado: (2021)

Paroxetine combined with olanzapine in the treatment of schizophrenia
por: Wang, Ning, et al.
Publicado: (2020)

Bio-behavioural changes in treatment-resistant socially isolated FSL rats show variable or improved response to combined fluoxetine-olanzapine versus olanzapine treatment
por: Mncube, K., et al.
Publicado: (2022)

Body Weight and Plasma Levels of Ghrelin and Leptin during Treatment with Olanzapine
por: Kim, Bong-Jo, et al.
Publicado: (2008)

Hyperglycemia associated with olanzapine treatment
por: Kumar, P. N. Suresh, et al.
Publicado: (2011)

Treatment of Delusional Infestation with Olanzapine
por: Kansal, Naveen Kumar, et al.
Publicado: (2012)

Weight gain with olanzapine: Drug, gender or age?
por: Jain, Sanjay, et al.
Publicado: (2006)

Comparison of efficacy of haloperidol and olanzapine in the treatment of delirium
por: Jain, Rajan, et al.
Publicado: (2017)

Effectiveness and safety of oral olanzapine treatment transitioned from rapid-acting intramuscular olanzapine for agitation associated with schizophrenia
por: Katagiri, Hideaki, et al.
Publicado: (2018)

Weight loss dynamics during combined fluoxetine and olanzapine treatment
por: Perrone, Jennifer A, et al.
Publicado: (2004)

The potential role of appetite in predicting weight changes during treatment with olanzapine
por: Case, Michael, et al.
Publicado: (2010)

Predictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in Japan
por: Ye, Wenyu, et al.
Publicado: (2011)

The gut microbiome influences the bioavailability of olanzapine in rats
por: Cussotto, Sofia, et al.
Publicado: (2021)

Pulmonary Thromboembolism Associated with Olanzapine Treatment
por: Wang, Qian, et al.
Publicado: (2015)

Olanzapine Induced Hyponatraemia
por: Dudeja, Sonia J, et al.
Publicado: (2010)

Pharmacovigilance on olanzapine
por: Lingeswaran, Anand, et al.
Publicado: (2010)

Teratogenicity with Olanzapine
por: Prakash, Sathya, et al.
Publicado: (2014)

Effectiveness and medication acceptance of olanzapine disintegrating tablets compared to standard olanzapine tablets in acutely treated psychiatric patients
por: Czekalla, Jörg, et al.
Publicado: (2007)

Characterization of Olanzapine-Solid Dispersions
por: Krishnamoorthy, Venkateskumar, et al.
Publicado: (2011)

Adjunctive treatment with aripiprazole for olanzapine-induced hyperprolactinemia
por: Bise, S., et al.
Publicado: (2022)

Eosinophilic myocarditis during treatment with olanzapine - report of two possible cases
por: Vang, Torkel, et al.
Publicado: (2016)

Seizure associated with olanzapine
por: Uvais, N. A., et al.
Publicado: (2018)

Reduced activity and connectivity of left amygdala in patients with schizophrenia treated with clozapine or olanzapine
por: Mier, Daniela, et al.
Publicado: (2018)

Combination of Olanzapine Pamoate with Melatonin and Metformin: Quantitative Changes in Rat Adipose Tissue
por: MIRON, IC, et al.
Publicado: ( 201)

Olanzapine Treatment of Adolescent Rats Causes Enduring Specific Memory Impairments and Alters Cortical Development and Function
por: Milstein, Jean A., et al.
Publicado: (2013)

Determination of Olanzapine and N-desmethyl-olanzapine in Plasma Using a Reversed-Phase HPLC Coupled with Coulochemical Detection: Correlation of Olanzapine or N-desmethyl-olanzapine Concentration with Metabolic Parameters
por: Lu, Mong-Liang, et al.
Publicado: (2013)

TMS-evoked EEG potentials demonstrate altered cortical excitability in migraine with aura
por: Helling, Robert M., et al.
Publicado: (2023)

Reasons for continuing or discontinuing olanzapine in the treatment of schizophrenia from the perspectives of patients and clinicians
por: Chen, Jian, et al.
Publicado: (2011)

Successful Treatment of Delusional Infestation with Olanzapine Depot
por: Vouk-Kamenski, Javor, et al.
Publicado: (2021)

Olanzapine-Induced Neutropenia
por: Malhotra, Kirti, et al.
Publicado: (2015)

Olanzapine-induced Psoriasis
por: Chepure, Ashish Hanmantrao, et al.
Publicado: (2017)

Olanzapine Treatment of Adolescent Rats Alters Adult D2 Modulation of Cortical Inputs to the Ventral Striatum
por: Brooks, Julie M., et al.
Publicado: (2016)

Perceptual Decision-Making in Children: Age-Related Differences and EEG Correlates
por: Manning, Catherine, et al.
Publicado: (2020)

Venous Thromboembolism as an Adverse Effect During Treatment With Olanzapine: A Case Series
por: Masopust, Jiri, et al.
Publicado: (2019)

Olanzapine–valproate combination versus olanzapine or valproate monotherapy in the treatment of bipolar I mania: a randomized controlled study in a Chinese population group
por: Xu, Lei, et al.
Publicado: (2015)

Alterations to Melanocortinergic, GABAergic and Cannabinoid Neurotransmission Associated with Olanzapine-Induced Weight Gain
por: Weston-Green, Katrina, et al.
Publicado: (2012)

Preventing Olanzapine-Induced Weight Gain Using Betahistine: A Study in a Rat Model with Chronic Olanzapine Treatment
por: Lian, Jiamei, et al.
Publicado: (2014)

Schizophrenia relapse after stopping olanzapine treatment during pregnancy: a case report
por: Ifteni, Petru, et al.
Publicado: (2014)

Olanzapine-induced methylation alters cadherin gene families and associated pathways implicated in psychosis
por: Melka, Melkaye G, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_j5aqc9pgda5j60g29dl1ln3dn3